CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03455387
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:36.910574+00:00
Published At: 2022-06-14T00:00:00+00:00
Record Updated At: 2022-06-14
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Pre-Eclampsia", "HELLP Syndrome", "Fetal Death", "Eclampsia", "Placental Abruption", "Fetal Growth Retardation, Antenatal"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-06-14"
protocolSection.identificationModule.nctId: "NCT03455387"
protocolSection.identificationModule.officialTitle: "Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.